Medicines containing active substance Autologous CD34+ cell enriched population that contains hematopoietic stem cells transduced with lentiglobin BB305 lentiviral vector encoding the beta-A-T87Q-globin gene
This site has the patient leaflet or the SPC of 1 medicine with the active substance autologous CD34+ cell enriched population that contains hematopoietic stem cells transduced with lentiglobin BB305 lentiviral vector encoding the beta-A-T87Q-globin gene.
- 1 autologous CD34+ cell enriched population that contains hematopoietic stem cells transduced with lentiglobin BB305 lentiviral vector encoding the beta-A-T87Q-globin gene only
Medicines containing only autologous CD34+ cell enriched population that contains hematopoietic stem cells transduced with lentiglobin BB305 lentiviral vector encoding the beta-A-T87Q-globin gene
| Medicine | Legal category |
|---|---|
| Zynteglo SPC | – |
ATC groups
The ATC classification sorts medicines by the organ they act on and by their effect – the group pages list the other medicines of the group too.
- B06A Other hematological agents 1 medicine
Sources: the MHRA product information and the European Medicines Agency (patient leaflets and SPCs), the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority (substances, ATC codes and legal categories). Contains public sector information licensed under the Open Government Licence v3.0. Ask your doctor or pharmacist which medicine is right for you.